Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Macrophage crosstalk inflames fat

July 10, 2020

Phase III data on Yselty in uterine fibroids support progression to regulatory filings

July 6, 2020

European Commission approves canagliflozin label update

July 2, 2020

Machine learning, GWAS divide and conquer PCOS

July 2, 2020

Placental attachment theory

July 2, 2020

FDA approves Dojolvi for long-chain fatty acid oxidation disorders

July 1, 2020

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group disclose S1P1 agonists

July 1, 2020

Preclinical studies show promise of GLP-1R agonist GL-0034 for treating diabetes

July 1, 2020

First phase I data presented for HM-15136

June 30, 2020

Japanese approval of Rybelsus for type 2 diabetes

June 29, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...